Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

POST-MARKETING SURVEILLANCE TO OBSERVE SAFETY AND EFFICACY OF XYNTHA SOLOFUSE PREFILLED SYRINGE

NCT03034044 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT03034044
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03034044 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
POST-MARKETING SURVEILLANCE TO OBSERVE SAFETY AND EFFICACY OF XYNTHA SOLOFUSE PREFILLED SYRINGE
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
January 31, 2017
Completion date
January 17, 2018
Enrollment
106 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

autosomal hemophilia a, classic hemophilia, factor 8 deficiency, congenital, factor viii deficiency, congenital, hemophilia a, congenital